ONYA THERAPEUTICS LIMITED

Company number 12443293 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£2,317,551

Balance sheet as at 2025-12-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2020-02-05
Employees
7 (2025 accounts)
Registered office
The Innovation Centre, Festival Drive, Ebbw Vale, United Kingdom, NP23 8XA
Postcode
NP23 8XA
Capital
7 GBP
Accounts category
Total Exemption Full

Accounts

Last made up to
2025-12-31
Next due by
2027-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2026-02-04
Next due by
2027-02-18
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 6 current

Subscribers only Director
Subscribers only Appointed 2026-03-30
Subscribers only Director
Appointed 2022-12-01
Subscribers only Secretary
Appointed 2022-02-28
Subscribers only Director
Appointed 2020-08-10
Subscribers only Director
Appointed 2020-02-05

View all officers and resignations →

Data protection registration

Registered with the ICO as a data protection fee payer — ZC280202 (Tier 1), registered since 2026.

Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.

Contact details

Website
onyatherapeutics.com

ONYA Therapeutics — From Care to Cure. Developing investigational Active Exudate Therapy for the treatment of chronic and acute wounds.

Among its peers

Top 25%

by shareholders' funds, of 12 similar companies in NP

Among the biggest employers among its local peers (7 staff).

Trading since 2020.

Competitors Newport

This company ranks 2 among research and experimental development on biotechnology in Newport.

Full league table →

The class of 2020

39%

of the 593 companies in this sector incorporated in 2020 are still active today; 55% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →